Core Viewpoint - Seer Medical experienced a significant stock price increase of 9.99%, reaching 34.24 CNY per share, with a trading volume of 7.02 billion CNY and a turnover rate of 11.0%, resulting in a total market capitalization of 6.54 billion CNY [1] Company Overview - Seer Medical Technology Group Co., Ltd. is located in Wuhan, specializing in medical intensive operation management services and has established partnerships with well-known IVD suppliers both domestically and internationally [1] - The company provides comprehensive supply chain services for in vitro diagnostic products and is further developing information technology to support the construction of intensive operation service platforms [1] - Seer Medical has deep investments in supply chain information technology, blockchain, and the Internet of Things, maintaining close cooperation with big data and information management system development companies [1] Financial Performance - For the period from January to March 2025, Seer Medical reported a revenue of 287 million CNY, representing a year-on-year decrease of 40.75% [1] - The net profit attributable to shareholders was -14.32 million CNY, reflecting a year-on-year decline of 553.66% [1] - As of March 31, the number of shareholders was 46,600, with an average of 4,099 circulating shares per person [1]

Core Viewpoint - The stock of Selys Medical experienced a significant increase of 10.02%, reaching a price of 31.52 yuan per share, with a trading volume of 1.519 billion yuan and a turnover rate of 26.46%, resulting in a total market capitalization of 6.021 billion yuan [1] Company Overview - Selys Medical Technology Group Co., Ltd. is located at 1310 Jinshan Avenue, Dongxihu District, Wuhan, and primarily operates in the field of medical intensive operation management services [1] - The company has established partnerships with well-known IVD suppliers both domestically and internationally, providing comprehensive supply chain services for in vitro diagnostic products [1] - Selys Medical is advancing its information technology capabilities to support the construction of an intensive operation service platform, with deep investments in supply chain information technology, blockchain, and the Internet of Things [1] Financial Performance - As of March 31, the number of shareholders for Selys Medical was 46,600, with an average of 4,099 circulating shares per person [1] - For the first quarter of 2025, Selys Medical reported an operating revenue of 287 million yuan, a year-on-year decrease of 40.75% [1] - The net profit attributable to shareholders was -14.32 million yuan, reflecting a year-on-year decline of 553.66% [1]

Core Viewpoint - The stock of Sealy Medical reached a 10.01% limit-up on August 19, trading at 32.86 yuan per share with a transaction volume of 905 million yuan and a turnover rate of 14.85%, resulting in a total market capitalization of 6.277 billion yuan [1] Company Overview - Sealy Medical Technology Group Co., Ltd. is located at 1310 Jinshan Avenue, Dongxihu District, Wuhan. The company primarily operates in the field of medical intensive operation management services and has established partnerships with well-known IVD suppliers both domestically and internationally [1] - The company provides comprehensive supply chain services for in vitro diagnostic products and is further developing information technology to support the construction of an intensive operation service platform [1] - Sealy Medical has a deep layout in information technology fields such as supply chain informatization, blockchain, and the Internet of Things, maintaining close cooperation with big data and information management system development companies [1] Financial Performance - As of March 31, Sealy Medical had 46,600 shareholders, with an average of 4,099 circulating shares per person [1] - For the first quarter of 2025, Sealy Medical reported an operating income of 287 million yuan, a year-on-year decrease of 40.75%, and a net profit attributable to shareholders of -14.32 million yuan, a year-on-year decrease of 553.66% [1]

Core Viewpoint - The stock of Saily Medical experienced a 5.13% increase on August 1, reaching 31.56 yuan per share, with a trading volume of 282 million yuan and a turnover rate of 4.77%, resulting in a total market capitalization of 6.029 billion yuan [1] Company Overview - Saily Medical Technology Group Co., Ltd. is located at 1310 Jinshan Avenue, Dongxihu District, Wuhan. The company primarily operates in the field of medical intensive operation management services and has established partnerships with well-known IVD suppliers both domestically and internationally [1] - The company provides comprehensive supply chain services for in vitro diagnostic products and is further developing information technology to support the construction of an intensive operation service platform. Saily Medical has a deep layout in supply chain information technology, blockchain, and the Internet of Things, maintaining close cooperation with big data and information management system development companies [1] Financial Performance - As of March 31, Saily Medical had 46,600 shareholders, with an average of 4,099 circulating shares per person [1] - For the first quarter of 2025, Saily Medical reported an operating income of 287 million yuan, a year-on-year decrease of 40.75%. The net profit attributable to shareholders was -14.32 million yuan, reflecting a year-on-year decline of 553.66% [1]